Patents by Inventor Christian Schwabe

Christian Schwabe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6949506
    Abstract: The present invention relates to a relaxin-like factor, its derivatives or analogs, and uses thereof. The present invention further relates to compositions comprising a relaxin-like factor, its derivatives or analogs, and relaxin wherein such composition exhibits an additive or synergistic effect.
    Type: Grant
    Filed: April 30, 2001
    Date of Patent: September 27, 2005
    Assignee: BAS Medical, Inc.
    Inventors: Christian Schwabe, Elaine Unemori
  • Publication number: 20030158376
    Abstract: The present invention relates to a relaxin-like factor, its derivatives or analogs, and uses thereof. The present invention further relates to compositions comprising a relaxin-like factor, its derivatives or analogs, and relaxin wherein such composition exhibits an additive or synergistic effect.
    Type: Application
    Filed: April 30, 2001
    Publication date: August 21, 2003
    Inventors: Christian Schwabe, Elaine Unemori
  • Patent number: 6582700
    Abstract: The present invention concerns a synthetic construct comprising a linear core chain having two or more side chains pending directly from different points on the linear core chain. Each of the side chains comprises an epitopic site of an antigen or a peptide. The synthetic constructs are monomeric units that can be linked together or polymerized to form a polymer. In this embodiment the epitopic sites of the side chains may be the same or different. The linear core chain may be a linear sequence of amino acids having two or more of the same peptide pending directly from different points on the linear sequence. Another aspect of the present invention concerns a support having one or more of the above synthetic constructs or polymers coupled thereto. Another embodiment of the present invention is directed to antibodies raised against the above synthetic constructs or polymers. The antibodies can be purified using the above mentioned supports.
    Type: Grant
    Filed: November 13, 1998
    Date of Patent: June 24, 2003
    Assignee: Medical University of South Carolina
    Inventor: Christian Schwabe
  • Patent number: 6200953
    Abstract: The present invention relates to a relaxin analogs and derivatives, and uses thereof. The present invention further relates to compositions comprising a relaxin analogs and derivatives, and relaxin wherein such composition exhibits an additive or synergistic effect.
    Type: Grant
    Filed: September 22, 1998
    Date of Patent: March 13, 2001
    Assignee: Connetics Corporation
    Inventors: Christian Schwabe, Elaine Unemori
  • Patent number: 5911997
    Abstract: The present invention relates to a relaxin-like factor, its derivatives or analogs, and uses thereof. The present invention further relates to compositions comprising a relaxin-like factor, its derivatives or analogs, and relaxin wherein such composition exhibits an additive or synergistic effect.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: June 15, 1999
    Assignee: Connetics Corporation
    Inventors: Christian Schwabe, Elaine Unemori
  • Patent number: 5827503
    Abstract: Oral hygiene is improved and diseases of the oral cavity are treated by oral application of a composition containing 0.02 to 0.25 weight percent alkyldimethylbenzylammonium chloride (BAC) and 0.05 to 2.0 weight percent sodium chloride dissolved in water, in the absence of other active ingredients. The BAC and sodium chloride act synergistically to allow the composition to sorb strongly to oral tissues and remain there for several hours.
    Type: Grant
    Filed: August 8, 1996
    Date of Patent: October 27, 1998
    Assignee: Collagenex Pharmaceuticals, Inc.
    Inventor: Christian Schwabe
  • Patent number: 5811395
    Abstract: The present invention relates to a relaxin analogs and derivatives, and uses thereof. The present invention further relates to compositions comprising a relaxin analogs and derivatives, and relaxin wherein such composition exhibits an additive or synergistic effect.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: September 22, 1998
    Assignees: Medical University of South Carolina, Connetics Corporation
    Inventors: Christian Schwabe, Elaine Unemori
  • Patent number: 5753711
    Abstract: In a method for preventing the spread of Helicobacter pylori from the oral cavity, the oral cavity is contacted with alkyldimethylammonium chloride. The contacting is advantageously used in conjunction with enteric antimicrobial therapy for H. pylori or for prophylaxis thereof.
    Type: Grant
    Filed: March 18, 1997
    Date of Patent: May 19, 1998
    Assignee: Collagenex Pharmaceuticals, Inc.
    Inventors: Christian Schwabe, Robert A. Ashley